← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #206 OF 1,000 MOST-CITED

Failure to wear

FDA cited this observation 114 times across 110 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods114
BY FISCAL YEAR
FY20202
FY20192
FY201853
FY201757

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1.1× the rate of the average FDA-cited firm (9.1% vs 8.3%), across 110 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your Professional access…

How FDA worded it — real examples

Failure to wear beard covers where appropriate.

Carfagnas Inc · Columbus, Ohio · Foods · 2020-02-07

Failure to wear hair nets, beard covers and hair restraints where appropriate.

Aiavolasiti's Mr. Wedding Cake Inc. dba Weiss Guy's Bakery · New Orleans, Louisiana · Foods · 2019-12-19

Failure to wear hair restraints where appropriate.

Cart Enterprise · Accra · Foods · 2019-06-27

Failure to wear hair nets and beard covers where appropriate.

Solid Gold, Inc. · Hyattsville, Maryland · Foods · 2018-10-03

Failure to wear beard covers where appropriate.

GTG Management, Inc. · Reisterstown, Maryland · Foods · 2018-09-14

Failure to wear hair nets, head bands, caps and hair restraints where appropriate.

Fresh Dough Co. · Woodland Park, New Jersey · Foods · 2018-09-12

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Quality risk managementFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →